← All trials
NCT06013956
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 29, 2023
- Primary completion
- Jun 30, 2028
- Completion date
- Jun 30, 2028
- First posted
- Aug 28, 2023
- Last posted
- Dec 6, 2023
- Enrollment
- 30
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- The Cleveland ClinicLead sponsor
- The Cleveland ClinicCollaborator
- The Cleveland ClinicSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.